The literature refers to an association of pathogenic variants of the MSH2 gene in over 90% of MTS patients, followed by the MLH1 gene, while just a few reports have associated MTS with MSH6 and PMS2. This evidence concerns the gene PMS2 and deafness dystonia syndrome.